Graduated in Modern Languages and Literatures, she earned a Master in Business Administration from L.U.I.S.S. University in Rome.
She began her career in 1991 at MSD Italia, first in Sales and then in Marketing, taking on increasing responsibilities until she joined the Worldwide Cholesterol Group of the parent company.

From 2003, she took on leadership roles in various departments: the Medin Business Unit, followed by the Cardiovascular-Metabolic Franchise and the companies of the MSD Group, Neopharmed and Gentili. At the same time, she managed the joint venture with Schering-Plough, later becoming Director of the Primary Care Business Unit.

In 2011, she was appointed Director of Market Access & Commercial Operations, expanding her expertise across MSD’s entire product portfolio.
In 2012, she was named President and CEO of Sanofi Pasteur MSD, the joint venture between Sanofi Pasteur—the vaccine division of Sanofi—and the vaccine division of MSD. Under her leadership, in 2014, SPMSD Italy became the top-performing affiliate in Europe, and in 2015, it secured first place in the prestigious “Great Place to Work®” ranking as well as the CEO of the Year award (Pharmaceutical Sector, Le Fonti Award).

In April 2015, she was appointed President of the Vaccines Group at Farmindustria.
On July 1, 2015, she assumed the role of President and CEO of MSD Italia, becoming the first woman to hold this position at the Italian subsidiary of the multinational pharmaceutical company Merck & Co.

In this capacity, she received the Salute 2015 Award for leadership in pharmaceutical innovation and for the excellence of digital services aimed at healthcare professionals and the public.